Advanced drug delivery systems can assist in managing influenza virus infection: A hypothesis

Chan, Y; Ng, SW; Mehta, M; Anand, K; Kumar Singh, S; Gupta, G; Chellappan, DK; Dua, K

Advanced drug delivery systems can assist in managing influenza virus infection: A hypothesis

Chan, Y Ng, SW Mehta, M Anand, K Kumar Singh, S Gupta, G Chellappan, DK Dua, K

Permalink

Publisher:: Elsevier
Publication Type:: Journal Article
Citation:: Medical Hypotheses, 2020, 144
Issue Date:: 2020-11-01

Open Access

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is open access.

The embargo period expires on 24 Sep 2021

Adobe PDF

Download Published versionAdobe PDF (1.42 MB)

View on publisher's site

View statistics

Full metadata record

Field	Value	Language
dc.contributor.author	Chan, Y
dc.contributor.author	Ng, SW
dc.contributor.author	Mehta, M
dc.contributor.author	Anand, K
dc.contributor.author	Kumar Singh, S
dc.contributor.author	Gupta, G
dc.contributor.author	Chellappan, DK
dc.contributor.author	Dua, K https://orcid.org/0000-0002-7507-1159
dc.date.accessioned	2020-12-03T05:00:01Z
dc.date.available	2020-12-03T05:00:01Z
dc.date.issued	2020-11-01
dc.identifier.citation	Medical Hypotheses, 2020, 144
dc.identifier.issn	0306-9877
dc.identifier.issn	1532-2777
dc.identifier.uri	http://hdl.handle.net/10453/144485
dc.description.abstract	© 2020 Elsevier Ltd Outbreaks of influenza infections in the past have severely impacted global health and socioeconomic growth. Antivirals and vaccines are remarkable medical innovations that have been successful in reducing the rates of morbidity and mortality from this disease. However, the relentless emergence of drug resistance has led to a worrisome increase in the trend of influenza outbreaks, characterized by worsened clinical outcomes as well as increased economic burden. This has prompted the need for breakthrough innovations that can effectively manage influenza outbreaks. This article provides an insight into a novel hypothesis that describes how the integration of nanomedicine, with the development of drugs and vaccines can potentially enhance body immune response and the efficacies of anti-viral therapeutics to combat influenza infections.
dc.language	en
dc.publisher	Elsevier
dc.relation.ispartof	Medical Hypotheses
dc.relation.isbasedon	10.1016/j.mehy.2020.110298
dc.rights	info:eu-repo/semantics/embargoedAccess
dc.subject	11 Medical and Health Sciences
dc.subject.classification	Neurology & Neurosurgery
dc.title	Advanced drug delivery systems can assist in managing influenza virus infection: A hypothesis
dc.type	Journal Article
utslib.citation.volume	144
utslib.for	11 Medical and Health Sciences
pubs.organisational-group	/University of Technology Sydney/Faculty of Health
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health/GSH.Pharmacy
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Health/Graduate School of Health
utslib.copyright.status	open_access	*
pubs.consider-herdc	true
utslib.copyright.embargo	2021-09-24T00:00:00+1000Z
dc.date.updated	2020-12-03T04:59:59Z
pubs.publication-status	Published
pubs.volume	144

Abstract:

© 2020 Elsevier Ltd Outbreaks of influenza infections in the past have severely impacted global health and socioeconomic growth. Antivirals and vaccines are remarkable medical innovations that have been successful in reducing the rates of morbidity and mortality from this disease. However, the relentless emergence of drug resistance has led to a worrisome increase in the trend of influenza outbreaks, characterized by worsened clinical outcomes as well as increased economic burden. This has prompted the need for breakthrough innovations that can effectively manage influenza outbreaks. This article provides an insight into a novel hypothesis that describes how the integration of nanomedicine, with the development of drugs and vaccines can potentially enhance body immune response and the efficacies of anti-viral therapeutics to combat influenza infections.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/144485